Buy Online vs Express Quote

First-class Customers Rely on InSphero technology

Pharma-Validated in Genentech and AstraZeneca Study

A landmark Archives of Toxicology article, “Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury” by our collaborators in the field, highlights the advantages of using 3D InSight™ Human Liver Microtissues for DILI prediction.

Will Proctor, Alison Foster, Simon Messner, Dominic Williams and several other notable experts

Our portfolio of 3D microtissues models and assay services for drug discovery and safety testing are also available through the Science Exchange marketplace for outsourced R&D. 

If your organization prefers to submit a requests through the Science Exchange network, click on the button below to visit our storefront.

Go to Science Exchange

Technology bettering biological research

For more than a decade, InSphero has developed and optimized technologies for robust and reproducible production, cultivation and assaying of 3D spheroids and organoids.

In countless successful collaboration projects with pharmaceutical and biotech partners, our technology has contributed to deep biological insights, better decisions and safer drugs.